Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Susan C. Winckler"'
Publikováno v:
Journal of the American Pharmacists Association
Autor:
Carla V Rodriguez-Watson, Amy C. Justice, Seth Kuranz, Frank de Wolf, Tom Brown, Nicolle M. Gatto, Anna Siefkas, Andrew Weckstein, Elizabeth Eldridge, Kelly Cho, Yuk-Lam Ho, Julius Asubonteng, Samson Mataraso, Daniel C Posner, Adem Albayrak, Carson Lam, Ritankar Das, Stuart L. Goldberg, Jonathan Hirsch, Andrew J. Belli, Qingqing Mao, Andrew Schrag, Ellen V. Sigal, Mark Stewart, Alice Gelman, Georgia D. Tourassi, Monika A Izano, Reyna Klesh, Amar Bhat, Andrew Ip, Eric Hansen, Susan C. Winckler, Hanna Gerlovin, Jeremy A. Rassen, Jeff Allen, Jason Jones, Robertino Mera
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248128 (2021)
PLoS ONE
PLoS ONE
Background The COVID-19 pandemic remains a significant global threat. However, despite urgent need, there remains uncertainty surrounding best practices for pharmaceutical interventions to treat COVID-19. In particular, conflicting evidence has emerg
Autor:
Joel W. Hay, Joan S. McClure, Lori Zablow-Salles, Charlie Dragovich, Daniel C. Malone, Jay Mcknight, Jennifer S. Graff, Eleanor M. Perfetto, Philip Naughten, Lisa Cashman, Terry Richardson, James K. Marttila, Jay Jackson, Soumi Saha, Elizabeth J. Cobbs, Russell Hoverman, Gergana Zlateva, Mary Jo Carden, Carly Rodriguez, Susan C. Winckler, Christopher Michael Blanchette, Craig Mattson, Kevin Bruns, Rhys Williams, Jeffrey Francer, Laurie B. Burke, Peter J. Neumann, Gregory W. Daniel, Laurie Wesolowicz, Susan A. Cantrell, Yanjun Carol Bao, Dan Danielson
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 22:826-831
The Food and Drug Administration Modernization Act (FDAMA) of 1997 included Section 114 as a regulatory safe harbor with the goal of increasing the dissemination of health care economic information (HCEI) to those responsible for formulary decision m
Autor:
Susan C. Winckler
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 72(9)
Thank you for the opportunity to be with you today. I am honored to deliver the lecture named for someone I met 21 years ago at a gathering of the Joint Commission of Pharmacy Practitioners (JCPP). I was the executive resident for the American Pharma
Autor:
Susan K. Bishop, Susan C. Winckler
Publikováno v:
Journal of the American Pharmaceutical Association (1996). 42:836-846
A worthy goal of HIPAA is to protect the privacy of patient health information. Final regulations for achieving this goal have been issued, and all covered entities, including all pharmacies that transmit health information electronically, must compl
Autor:
Elizabeth A. Chrischilles, Susan C. Winckler, Patricia J. Byrns, Michael T. Rupp, Michelle A. Chui, Thomas R. Fulda
Publikováno v:
Journal of the American Pharmaceutical Association (1996). 42:439-448
Objective To describe the controversies and review the evidence about computer-aided prospective drug utilization review (PDUR) systems. Data Sources MEDLINE search of the literature. Study Selection Published studies of the effectiveness of computer
Autor:
Susan C. Winckler
Publikováno v:
Journal of the American Pharmaceutical Association (1996). 41:501-507
Autor:
Susan C. Winckler
Publikováno v:
Journal of the American Pharmaceutical Association (1996). 36:299-342
Autor:
Susan C Winckler
Publikováno v:
Journal of painpalliative care pharmacotherapy. 16(4)
Extemporaneous compounding of medications has been an integral component of the practice of pharmacy and medicine since the practices began. A staple of early medical and pharmacy practice, even today many patients benefit from compounding at some po
Autor:
Susan C. Winckler
Publikováno v:
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996). 39(5)